Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors

被引：0
|
作者：
Motomura, K. [1 ]
Ishitobi, M. [1 ]
Komoike, Y. [1 ]
Koyama, H. [1 ]
Nagase, H. [2 ]
Inaji, H. [1 ]
Noguchi, S. [3 ]
机构：
[1] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan
[2] Taiho Pharmaceut Co Ltd, Personalized Med Res Lab, Tokushima, Japan
[3] Osaka Univ, Grad Sch Med, Osaka, Japan
来源：
BREAST | 2009年 / 18卷
关键词：
D O I：
10.1016/S0960-9776(09)70091-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] Expression of Estrogen Receptor Beta and Phosphorylation of Estrogen Receptor Alpha Serine 167 Correlate with Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Aromatase Inhibitors
    Motomura, Kazuyoshi
    Ishitobi, Makoto
    Komoike, Yoshifumi
    Koyama, Hiroki
    Nagase, Hideki
    Inaji, Hideo
    Noguchi, Shinzaburo
    [J]. ONCOLOGY, 2010, 79 (1-2) : 55 - 61
  • [2] Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer
    Yamashita, H
    Nishio, M
    Kobayashi, S
    Ando, Y
    Sugiura, H
    Zhang, ZH
    Hamaguchi, M
    Mita, K
    Fujii, Y
    Iwase, H
    [J]. BREAST CANCER RESEARCH, 2005, 7 (05): : R753 - R764
  • [3] Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer
    Hiroko Yamashita
    Mariko Nishio
    Shunzo Kobayashi
    Yoshiaki Ando
    Hiroshi Sugiura
    Zhenhuan Zhang
    Maho Hamaguchi
    Keiko Mita
    Yoshitaka Fujii
    Hirotaka Iwase
    [J]. Breast Cancer Research, 7
  • [4] Association of the phosphorylation of the estrogen receptor at serine 118 and 167 with prognosis in postmenopausal breast cancer patients
    Beelen, Karin J.
    Opdam, Mark
    Koornstra, Rutger H. T.
    Vincent, Andrew D.
    Vermorken, Jan Baptist
    van Diest, Paul J.
    Sanders, Joyce
    Wesseling, Jelle
    Linn, Sabine C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] High phosphorylation of estrogen receptor α serine 167 and low p53 protein accumulation improve survival in estrogen receptor-positive breast cancer patients treated with tamoxifen
    Sugiura, H.
    Toyama, T.
    Kondo, N.
    Kobayashi, S.
    Fujii, Y.
    Yamashita, H.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S243 - S243
  • [6] Elacestrant Improves Progression-Free Survival After Endocrine Therapy for Estrogen Receptor-Positive Metastatic Breast Cancer
    Jacobson, Anne
    [J]. ONCOLOGIST, 2022, 27 : S7 - S8
  • [7] Elacestrant Improves Progression-Free Survival After Endocrine Therapy for Estrogen Receptor-Positive Metastatic Breast Cancer
    Jacobson, Anne
    [J]. ONCOLOGIST, 2022, 27 (SUPPL 1): : S7 - S8
  • [8] Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target
    Skliris, George P.
    Leygue, Etienne
    Watson, Peter H.
    Murphy, Leigh C.
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2008, 109 (1-2): : 1 - 10
  • [9] Phosphorylation of Estrogen Receptor β at Serine 105 in Primary Breast Cancer
    Hamilton-Burke, W. L. S.
    Shaaban, A. M.
    Cummings, M.
    Holliday, D. L.
    Pollock, S.
    Horgan, K.
    Speirs, V
    [J]. CANCER RESEARCH, 2009, 69 (24) : 754S - 754S
  • [10] Low phosphorylation of estrogen receptor a (ERα) serine 118 and high phosphorylation of ERα serine 167 improve survival in ER-positive breast cancer
    Yamashita, Hiroko
    Nishio, Mariko
    Toyama, Tatsuya
    Sugiura, Hiroshi
    Kondo, Naoto
    Kobayashi, Shunzo
    Fujii, Yoshitaka
    Iwase, Hirotaka
    [J]. ENDOCRINE-RELATED CANCER, 2008, 15 (03) : 755 - 763
12345